1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Dry Eye Products Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Dry Eye Products Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Dry Eye Products Market Regional Analysis
6.2 North America Dry Eye Products Market Revenue 2021-2031 (US$ Million)
6.3 North America Dry Eye Products Market Forecast Analysis
7. North America Dry Eye Products Market Analysis – by Product
7.1 Artificial Tears
- 7.1.1 Overview
- 7.1.2 Artificial Tears: North America Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Anti-Inflammatory Drugs
- 7.2.1 Overview
- 7.2.2 Anti-Inflammatory Drugs: North America Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Punctal Plugs
- 7.3.1 Overview
- 7.3.2 Punctal Plugs: North America Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Secretagogues
- 7.4.1 Overview
- 7.4.2 Secretagogues: North America Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Oral Omega Supplements
- 7.5.1 Overview
- 7.5.2 Oral Omega Supplements: North America Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. North America Dry Eye Products Market Analysis – by Dosage Form
8.1 Eye Drops
- 8.1.1 Overview
- 8.1.2 Eye Drops: North America Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Gel
- 8.2.1 Overview
- 8.2.2 Gel: North America Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Capsules
- 8.3.1 Overview
- 8.3.2 Capsules: North America Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Tablets
- 8.4.1 Overview
- 8.4.2 Tablets: North America Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. North America Dry Eye Products Market Analysis – by Type
9.1 OTC
- 9.1.1 Overview
- 9.1.2 OTC: North America Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Prescription
- 9.2.1 Overview
- 9.2.2 Prescription: North America Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. North America Dry Eye Products Market Analysis – by Distribution Channel
10.1 Retail Pharmacy
- 10.1.1 Overview
- 10.1.2 Retail Pharmacy: North America Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.2 Hospital Pharmacy
- 10.2.1 Overview
- 10.2.2 Hospital Pharmacy: North America Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.3 Online Pharmacy
- 10.3.1 Overview
- 10.3.2 Online Pharmacy: North America Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
11. North America Dry Eye Products Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America Dry Eye Products Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 11.2.1.1 North America Dry Eye Products Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.1.1 US: North America Dry Eye Products Market Breakdown, by Product
- 11.2.1.1.2 US: North America Dry Eye Products Market Breakdown, by Dosage Form
- 11.2.1.1.3 US: North America Dry Eye Products Market Breakdown, by Type
- 11.2.1.1.4 US: North America Dry Eye Products Market Breakdown, by Distribution Channel
- 11.2.1.2 Canada:
North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.2.1 Canada: North America Dry Eye Products Market Breakdown, by Product
- 11.2.1.2.2 Canada: North America Dry Eye Products Market Breakdown, by Dosage Form
- 11.2.1.2.3 Canada: North America Dry Eye Products Market Breakdown, by Type
- 11.2.1.2.4 Canada: North America Dry Eye Products Market Breakdown, by Distribution Channel
- 11.2.1.3 Mexico :
North America Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.3.1 Mexico : North America Dry Eye Products Market Breakdown, by Product
- 11.2.1.3.2 Mexico : North America Dry Eye Products Market Breakdown, by Dosage Form
- 11.2.1.3.3 Mexico : North America Dry Eye Products Market Breakdown, by Type
- 11.2.1.3.4 Mexico : North America Dry Eye Products Market Breakdown, by Distribution Channel
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Santen Pharmaceutical Co Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Johnson & Johnson
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 OASIS Medical
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 URSAPHARM Arzneimittel GmbH
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Rohto Pharmaceutical Co Ltd
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 OCuSOFT Inc.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Bausch Health Companies Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 AbbVie Inc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Prestige Consumer Healthcare Inc.
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Farmigea SpA
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Alcon AG
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations